Since the genomic era is a reality nowadays, we need deeper understanding and consideration upon the benefits and challenges it brings. Apart from all the enthusiasm, there are also concerns related to genomics, specifically to the use and storage of personal genetic information as well as concerns regarding, for instance, so-called incidental findings, and right not to know.
engineering, researchers are provided with an improved and expanded repertoire of research tools to analyse any organism in health and disease [3] [4] [5] 
New solutions and first milestones in exploring human genetic variation
One of the first catapulting techniques was microarray technology and this was followed by genomic and clone-based techniques [3, 4, 6, 7] . Sanger's chain-termination sequencing method and the current next-generation sequencing (NGS) techniques have subsequently revolutionised genetics.
The first method has been in used since several decades and helped in a large number of scientific milestones, including first draft of entire human genome completed in April 2003 and released by the Human Genome Project Consortium. The second method, NGS, is currently the most abundantly used technique and it is expected that further cost reduction, accompanied by increases in efficiency and accuracy, will make NGS increasingly available [3, 8] . New technological solutions have already emerged the market including the use of nanopores and pyrosequencing, substantially improving read-depth and read-length. Whilst Sanger's sequencing method and NGS are widely known, nanopores and pyrosequencing are still making their way to the global market. The first technique uses nanopores and ionic current being passed through those membrane nano-scale pores, measuring the current changes when biological molecules moves through the pore. This change in current is detected and used to precise identification of the biological molecule -base of the nucleic acid [9] , [10] . The last and the least known method, pyrosequencing, is similar to Sanger's sequencing by synthesis concept, however it focuses on light detection when pyrophosphate is released during the chain reaction, thus uses another enzyme, usually luciferase [11] .
Applications of those methods seem almost endless (see Figure 1 ) but genetic variation remains the most important area of study [6, 12] . Human genomics is an applied science and genetic variation in relation to diseases remains the most common application of genomic information [3, 13] . Genome-Wide Association Studies (GWAS) have identified a vast amount of loci associated with more than 200 phenotypes [14] .
Understanding these heritable, as well as environmental, factors is crucial in the anticipation of disease triggers, and has considerable potential in minimising disease impact [3] . New treatment targets are emerging in all areas but especially in cancer management and diagnostics can even be extended preimplantation using in vitro PGD (Preimplantation Genetic Diagnosis) [15, 16] .
| Additional Box 1. Human genome variation terminology overview

One omic to rule them all
We are well on our way to introducing publicly-available genome-based screening and diagnostics. This will revolutionise medicine by enabling predictions about disease susceptibility, early detection correct classification, drug dose assessment and individually-selected treatment [3, 5] . This should be followed by healthy-lifestyle studies and the promotion of preventive medicine, including the importance of healthy diet, exercise and ecological solutions in everyday life.
Nutrigenomics and the genetic changes of physical activity remain exciting but virtually undiscovered fields. Currently used omics 1 technologies also have the synergistic potential to trigger significant change beyond human-related disciplines. For example, recent analyses of permafrost microbiome multi-omics [17, 18] as well as near imperceptible molecules such as inulin, provided important new insights using metagenomics and metabolomics [19] [20] [21] . So, what is omics? It is a neologism referring to any biological filed ending with -omics, such as genomics or proteomics. It originated in Greek suffix -ome widely used in medical and biological sciences meaning "total", "a whole" [22] , [23] .
Additional Box 2. Examples of "omics"
Apart from pathogenic alleles, some variants are associated with resistance to disease, pathogens or drugs whereas others are connected with healthier and longer life [3] . Large-cohort studies should be carried out particularly among those healthy individuals known to be exposed to environmental risk factors, such as obesity, sedentary lifestyle, smoking and air pollution [3] .
However, there are considerable problems in translating genomic knowledge into health care. All the benefits and applications mentioned above have potential impact on society and privacy, including the problem of the right to know and the right not to know [24] [25] [26] [27] . There is also the problem that a statistical predictive value is not easily transformed to a prediction for a particular person.
Genomic and Epigenomic complexity
Integrated information from many different fields may help in determining how genome components interplay with each other and how they perform their functions at cellular and organismal levels, in a state of health and disease [3] . Despite the fact that DNA is a relatively simple and well-known molecule today, the structure of the human genome remains poorly understood [3, 28] . The extraordinary complexity of the genome is determined not only by its chemistry, but by its complicated mechanisms. Only around 2% of the base sequence encodes proteins, and the rest of the human genome is non-coding ( Figure 2 ). This does not mean it is junk.
On the contrary, the non-coding sequence contains important regulatory elements, most of which are yet to be determined [3] . The final amino acid composition of protein cannot be accurately predicted simply from the protein-coding sequence of DNA. In fact, most variation is located in noncoding regions so discovery and validation of all functional elements of the genome is an important goal. This is already being tasked by projects such as ENCODE [14, 28] . [3, 29] . Alternative gene splice forms are well described but their regulatory regions and regulatory elements are still poorly understood [3] . A crucial contribution might be the non-coding RNAs, currently investigated extensively especially in a cancer research area, such as miRNAs. miRNAs are small, non-coding fragments of RNA capable of complementary binding to the target-sequence and it is estimated they regulate over 60% of genes in the human genome [14] . There are over 3000 miRNAs and their families described in the miRBase and dPORE-miRNA; the latter a catalogue of human variants affecting miRNAs [14, 32] . Since genetic variation may also affect genome regions coding miRNAs, pathways regulated by those miRNAs might be interrupted, leading to disease [14, 28] .
Equally important is a better understanding of epigenetic changes. Epigenetic modification of DNA molecules, histones and chromatin remodelling can actively respond to environmental changes. In addition, one amino acid residue can be "affected" by more than one modification, and more importantly -most epigenetic modifications seem to be reversible [33, 34] . Cancer cells contain a significant number of epigenetic changes, compared with healthy cells. Global hypomethylation, the first epigenetic modification discovered, is the subject of much speculation and much research into the possible impact of epigenetic alterations in carcinogenesis [33, 35] . Gene silencing, for example of tumour-suppressor genes, is another interesting but not fully understood mechanism strongly connected with tumours [33, 36] . Epigenetic changes also occur widely during inflammation, another phenomenon extremely important in cancer disease, but many details of this process are yet to be discovered [33] .
Bioinformatics and Systems Biology as a future approach
A systemic approach is the pathway of the future and will involve real-time analyses of gene expression, entire genome functioning as well as the cell as a whole [3, 35] . Improvement of imaging techniques might be helpful in non-invasive cellular phenotyping [3] . A complete and well- Knowing the internal environment is not enough. The interplay between genome elements as well as between genes and environmental factors should be investigated empirically along with advanced computational methods. The impact of factors such as lifestyle, kinship, ethnicity and socioeconomic background should not be neglected in any research [3, 28] .
Understanding how the genome changes and gains new elements is the concern of evolution-related NGS investigations [3] . Comparisons of sequences from different organisms demonstrate important information about their ancestry and importance across species [3] .
Understanding human genetic variation thus involves investigation of several other model organisms including bacteria, nematode and the fruitfly [3, 18, 41] . Thus, experiments on relatively simple organisms can bring researchers closer to many solutions and limit the number of investigations on more complex and ethically controversial human material [3] . Mutational processes and genomerepair mechanism are further important areas of research as these processes are involved in both disease and long-term evolutionary changes. Their importance was recently demonstrated in discoveries of a differentiated mutational rate across the genome and in the studies on DNA repair mechanisms that gained the Nobel Prize in Chemistry in 2015 [3] .
Synthetic biology is worth mentioning, although it remains outside of the main remit of this paper. It is a rising discipline, fusing engineering principles to create biological components and even entire cells. Since most of basic research in biology-related disciplines is focused on understanding biological and molecular functions of every chemical substance and every gene in a cell, one thrilling way to achieve this is to create a minimal genome that includes only the genes essential for life [42] .
Having such a minimal model would allow for further studies on the most crucial genes variation in silico.
The diversity of life is a result of adaptation processes in response to environmental demands. Our knowledge of adaptation and evolution on molecular level remains limited. To fill this gap, some laboratories have already introduced a new technique called 'Evolve and Resequence'.
This uses experimental evolution and modelling to detect genome changes as a result of adaptation and can monitor molecular evolution nearly real-time, with the aid of NGS [43] . While lab-induced evolution may not fully reflect what occurs in the wild, it provides some clues for further investigation [28, 43] .
Tracing back human ancestry
Thanks to comparative genomics it is possible to find evolutionary-conservative regions of the human genome. Within these regions variation is extremely rare and genes located there are usually vital to development. Knowledge about highlyconservative genes is of utmost importance as it provides information about biological consequences of mutation: the more conservative the gene, the more severe phenotype, if mutated[13].
The sequencing revolution has challenged many traditionally-used terms, such as 'gene' or 'human race'. Although questionable, those terms are far from being biologically meaningless [44] . Many forensic and medical databases typically cluster individuals according to ethnicity or racial categories, which might be useful when it comes to selective drug-response as a result of variation [44] . It is wellknown that some diseases are more common among certain populations, e.g. the sickle-cell disease is prevalent in African and Mediterranean populations whereas hemochromatosis and cystic fibrosis are more common in northern Europeans [44] . Similarly, drug-response as a result of genomic variation, can differ on average among populations. The utility of this is controversial but areas regularly cited are a lower response to ACE-inhibitors observed in African-Americans and ethnic variation in depression treatment: even though there are some clear differences, it remains unclear if they are clinically significant [44] . Thus, we should bear in mind that statistical significance does not necessarily goes in line with the biological relevance nor functioning.
Humans are very similar to one another, with the largest genetic distance located between
African and non-African populations. The 'roots' of anatomically-modern-humans evolutionary tree
Similar or different?
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Humans evolved on the African continent and had enough time to accumulate genetic diversity but only a small population left the continent and experienced a bottleneck [28, 44] . An increase in population size results in greater diversity (as occurred in Africa over thousands of years) but migration and isolation can promote unique population allele patterns. Some may not be beneficial if whole populations, such as Ashkenazi Jews, are considered. [45] . Palaeolithic revolution and rapid population growth were possible thanks to improved living conditions, but the same is also responsible for an excess of damaging variants in our genome [46, 47] . 
The need for integrative and accessible database
All the technologies mentioned generate so much data it cannot be handled by one single laboratory or research centre. Efforts are therefore organised to study one single trait or disease whereas both national and international consortia attempt to analyse one particular topic, like bladder cancer or Crohn Disease [3] . This does not mean that most of the data generated so far is wasted. Research in the past was simply insufficiently coordinated and the data were widely
The solution is integrated bioinformatics and highly-developed computational infrastructure for storage and management of data [3, 50] . The biomedical research of tomorrow cannot exist without integrated computational methods and well-trained specialists, softwaredesigners, data-homing devices and special methodology [3, 50, 51] . Data integration is particularly challenging in tumour biology not only due to the high complexity, but also because most of computational tools require completely different file types [52] . Scientists now have to write their own scripts in order to 'glue' software together [52] . It is important to bear in mind that bioinformatics results are not just the preserve of the researcher. The information must be accessible and understandable for healthcare providers, pharma-related users, scholars, students and maybe also patients or even the public [3, 53, 54] . According to MIT Broad Institute there are over 10,000
bioinformatic tools (including those on platforms like Galaxy, GenomeSpace or GenePattern) and nearly 5,000 different databases. This amount of data must be clustered in order to improve scientific data sharing [52] [53] [54] [55] .
Development of complete, constantly updated, easy-to-use and fully-accessible databases are a crucial need in the genomic era, especially in multi-omics, where everything is interconnected [3, 50, 52, 53] . Many have already emerged, such as The Human Variome Project, The
African Genome Variation Project and The Cancer Genome Atlas [12, 52, 56, 57] . High tumour heterogeneity, genome instability and multi-mutation pathways can cause exactly the same cancer phenotype [52] . This is particularly challenging in terms of gathering data and designing reliable software. The identification of drivers and passengers among cancer mutations is an ongoing . Examples of driver mutations in selected cancer types [58] , [60] , [61] , [62] Which brings us to pharmacogenomics. An incredibly promising discipline interconnected with all other aforementioned sciences. The interplay between genetic and non-genetic factors (e.g.
gene variants and environmental factors) forms a background for variable responses to drugs [3, 28] .
Knowing disease aetiology and molecular pathways in detail has allowed the development of new, highly specific and effective drugs including the huge success of Gleevec (imatinib mesylate) in myelogenous leukaemia treatment [3] .
Gene therapy has been in use for a variety of monogenic diseases since the 1990s, when it was first used to treat a girl with ADA enzyme deficiency (SCID spectrum). It will advance with increased understanding of human genome complexity, especially in cancer therapy ( Figure   5 ) [13, 63] . A multitude of applications is generated by immunology. The human immune system is extremely complicated and yet poorly understood at molecular level. Using a molecular approach and harnessing bioinformatical tools it is now possible to generate well-defined vaccines, which are highly immunogenic, effective and safe [64, 65] . Of particular interest is an area of the human genome, called MHC (Major Human Histocompatibility Complex), located on chromosome 6p21 [66, 67] . It is said to be the most densely-packed area of human genome, containing genes mostly connected with immunity. There is significant inter-populational variation and over 100 different diseases have been found in relation to MHC-genes [66] . Immunology is also tightly connected with virology and microbiology, all of which apply NGS techniques extensively. Examples include the identification of HIV genetic variability and mutation rates, the first parasite genome sequencing (Plasmodium) as well as variants of leukocyte surface-antigens that are involved in viral interactions [18, 65, [68] [69] [70] .
From bench to bedside -the need for professionals and legislation
Translating medical achievements and advanced technologies into clinical use, with availability to the average patient in every country, remains not only a dream today but a challenge for the future. Despite huge enthusiasm around the Human Genome Project and all omicstechniques, only a few omics-based clinical tests have translated to direct patient care thus far [71] .
To accelerate this process of clinical application special guidelines were issued in late 2013 [71] .
HGP has had another significant implication, less extensively underlined in the media, in that it has created a large number of academics in clinical research, genetics, genomics, bioinformatics, ethics, law, social sciences and public policy [3] . It has also increased public awareness significantly and made an attempt to introduce legal protection against the misuse of personal genetic information, especially among insurance companies and employers [3] . Genetic law remains an open book, being varied and unclear across jurisdictions. These uncertainties generate space for potential abuses and future misuse and extend into areas of intellectual property, licensing, clinical/private usage and commercialization [3, 51] . Difficulties may be accentuated in cultural and religious contexts. Direct-to-consumer (DTC) testing provides lay people with an enormous amount of information about human genetic variation. Such databases are already used for research purposes, providing a unique insight into our diversity. Yet, DTC testing companies declare "personalised advice" for every client, which in most cases is an impossible promise. For example, we simply do not have enough data to say how genetic variants are involved in diet or exercise-related pathways. Also, predictive testing of children by their parents remains highly questionable, and their right to know or not to know is in danger [74, 75] . To exemplify this, the sharp image of Huntington's disease could be considered: should the child of twelve know about its possible future disease, for which modern medicine has nearly nothing to offer? Above all, genetic test results must always be interpreted by a specialist and discussed with a patient to avoid any misleading information or misunderstandings.
The future is now
It is clear that the increased availability of new genetic technologies and information should be followed by proper education of both specialists and society [3] . WGS and WES are now routinely used both in scientific research and clinics but the demand for skilled and well-trained professionals exceeds the supply [76, 77] . Researchers are now under pressure to have not only field-specific skills and knowledge, but also basic computational and bioinformatics skills. Genomics is with us now and new generations of scientists must be well-prepared through evolving, specifically tailored university programs that have interdisciplinary purpose [3, 5, 76] . Interdisciplinary teams should be formed in every laboratory in the near future [3, 77] .
Health professionals should also be aware of the benefits and risks connected with genetic information and genomic analysis and some universities have even introduced optional and free-ofcharge WGS for their students [76] . Participants reported that having their own genome sequenced was of great help. Genome analysis enhanced their motivation to study harder, to search for more information and dig deeper into scientific literature. They also admitted to being more involved, engaged and excited about learning genome analysis and were motivated to spend their evenings studying [76] .
Genetics and genomics are of great interest to both the public and health professionals, therefore education and reliable information sources are the key to future success ( Figure 6 ).
Genomic tests are widely available now and population screening is being introduced [3, 5, 77] . The media remain the main source of information so it is important to educate their staff, as well as to cooperate in medicine-related program production. Proper delivery of genetic information to the patient remains crucial to the understanding of the patient's health status and allow treatment decisions appropriate to their disease, socioeconomic status, country of residence etc. [3, 5, 78] . Thus, the practice, theory and ethics of genetic counselling is strongly required. Unfortunately, in many countries, genetic counselling is limited or absent and society access to genetic advice is therefore minimal.
Conclusions
To summarise, genes and gene products rarely act independently but they rather form complex and interconnected pathways and networks. Taken together the systems, can explain the functioning of cells, tissues and entire organisms. It is important to emphasize that the genome is a highly complex and dynamic structure that continually responds to environmental factors, being subjected to changes by evolution and its forces.
Nearly every disease has a genetic component, usually polygenic, in a similar way to human traits and behaviour. Vast amounts of generated data make it difficult to assess the validity and interpretation of results. Progress in genomics should inevitably be interconnected with advances in several other disciplines, especially when it comes to non-medical usage of genetic information and possible discrimination such as in the legal system, military and safety, education, as well as public, regulatory, policy-maker and governmental awareness.
Bearing in mind how challenging genetic research is and how complex the human genome is, why do we still keep on analysing it? Maybe the answer is very complex but it might also be disarmingly simple: to understand our own biology better. 
